CARNISURE 500MG TABLET 10'S

Carnisure 500 is a prescription medicine that contains levocarnitine (L-carnitine) 500 mg as its active ingredient. Levocarnitine is a naturally occurring compound involved in energy production, particularly in the transport of long-chain fatty acids into mitochondria for oxidation. Carnisure 500 is used to treat or prevent carnitine deficiency in selected clinical conditions under medical supervision.

Carnisure 500 is primarily used to manage primary systemic carnitine deficiency and secondary carnitine deficiency associated with conditions such as chronic kidney disease (especially in patients on dialysis), certain liver diseases, inborn errors of metabolism, and long-term use of specific medicines like valproic acid. It may also be used as an adjunct in some patients with heart failure, cardiomyopathy, peripheral vascular disease, or muscle disorders when carnitine deficiency is suspected or documented. Its use should always be based on a doctor’s assessment.

Levocarnitine in Carnisure 500 facilitates the transport of long-chain fatty acids across the inner mitochondrial membrane, allowing them to be broken down to produce energy. It also helps remove acyl groups and toxic metabolites from cells, supporting normal cellular metabolism. In states of carnitine deficiency, these processes are impaired, leading to fatigue, muscle weakness, or organ dysfunction. By restoring carnitine levels, Carnisure 500 can improve energy utilization and metabolic balance in appropriate patients.

Carnisure 500 should be taken exactly as prescribed by your doctor. It is usually taken by mouth, with or without food. Some patients may tolerate it better with meals if they experience stomach upset. The dose, frequency, and duration of treatment are individualized based on age, body weight, laboratory results, and the underlying condition. Do not change the dose, start, or stop the medicine without consulting your healthcare provider. Swallow the tablet with water and do not crush or chew it unless your doctor specifically advises otherwise.

Common side effects of Carnisure 500 include nausea, vomiting, abdominal discomfort, diarrhoea, and a fishy body odour or breath. Some people may experience headache, muscle cramps, or mild weakness. These effects are often dose related and may improve if the dose is adjusted or the medicine is taken with food. If side effects are persistent, troublesome, or worsening, you should contact your doctor for advice. Severe or unusual symptoms, such as difficulty breathing, swelling, or severe rash, require urgent medical attention.

Levocarnitine has been associated with an increased risk of seizures in some patients, particularly those with a pre-existing seizure disorder or those receiving high doses. If you have epilepsy or a history of seizures, your doctor will carefully weigh the potential benefits and risks before prescribing Carnisure 500 and may monitor you more closely. Any new onset of seizures, change in seizure frequency, or unusual neurological symptoms should be reported to a healthcare professional immediately.

Carnisure 500 is often used in patients with chronic kidney disease, especially those on dialysis, because they are at higher risk of carnitine deficiency. However, dosing and monitoring in kidney disease must be individualized. In patients with reduced kidney function, accumulation of metabolites is possible, and the doctor may adjust the regimen and monitor for side effects such as gastrointestinal symptoms or changes in mental status. You should not start or continue Carnisure 500 in kidney disease without regular medical follow-up.

Data on the use of levocarnitine during pregnancy are limited. Animal studies do not suggest major harm at therapeutic exposures, but well-controlled studies in pregnant women are lacking. Carnisure 500 should only be used during pregnancy if the potential benefit justifies the potential risk to the mother and fetus, as assessed by a doctor. If you are pregnant, planning a pregnancy, or become pregnant while taking Carnisure 500, discuss the situation promptly with your healthcare provider.

Levocarnitine is a natural component of human milk, and small amounts from medicinal use may pass into breast milk. The clinical significance of this exposure for the breastfed infant is not fully established. Carnisure 500 should be used during breastfeeding only when clearly needed and after a risk–benefit discussion with your doctor. If you are breastfeeding, inform your healthcare provider before starting Carnisure 500 so that appropriate monitoring of the infant can be considered if necessary.

Levocarnitine has relatively few well-documented drug–drug interactions, but it is often prescribed in complex clinical situations where multiple medicines are used. It may be given together with drugs such as valproic acid to help manage or prevent carnitine depletion, but this should be done under specialist supervision. Alcohol does not have a specific known interaction with levocarnitine, but excessive alcohol intake can worsen underlying liver, heart, or muscle conditions for which Carnisure 500 may be prescribed. Always inform your doctor and pharmacist about all medicines, supplements, and herbal products you are taking, and limit or avoid alcohol as advised.

Carnisure 500 can be used in both paediatric and elderly patients when there is a documented or strongly suspected carnitine deficiency, but dosing and monitoring must be individualized. In children, treatment is usually supervised by a paediatrician or metabolic specialist, and growth, development, and laboratory parameters are monitored regularly. In elderly patients, coexisting kidney, liver, heart, or neurological conditions and concomitant medications must be carefully considered. Neither children nor older adults should receive Carnisure 500 without a clear medical indication and close follow-up.